| Product Code: ETC8837128 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Carotid Artery Disease Market in the Philippines is expanding as awareness of stroke prevention and cardiovascular health grows. The increasing prevalence of hypertension, smoking, and sedentary lifestyles has contributed to a rise in carotid artery disease cases. The healthcare system is gradually incorporating more diagnostic and interventional solutions, although access to advanced care remains limited in rural areas.
The Carotid Artery Disease market in the Philippines is growing due to the rising prevalence of cardiovascular diseases and an aging population. Carotid artery disease, a condition where the carotid arteries become narrowed or blocked, increases the risk of stroke. The market is driven by the demand for diagnostic devices, such as ultrasound imaging and CT scans, as well as treatment options, including surgical procedures and stenting.
Carotid artery disease in the Philippines is affected by high levels of cardiovascular risk factors, such as hypertension, diabetes, and high cholesterol, which lead to an increasing demand for treatment options. However, there are challenges related to the underdiagnosis and underreporting of the disease, as many patients may not experience symptoms until the condition is advanced. The high costs of advanced diagnostic techniques and treatment options, such as carotid endarterectomy or stent placement, also pose a barrier to widespread treatment, particularly in underfunded healthcare settings.
With a growing aging population and increasing prevalence of lifestyle diseases, the market for carotid artery disease treatments in the Philippines is poised for growth. Carotid artery disease, which can lead to stroke, requires timely intervention and medical management. Investment opportunities exist in the development of advanced imaging techniques, medical devices for carotid artery stenting, and pharmaceutical treatments. Establishing specialized care centers and building awareness campaigns for prevention and early detection can also play a crucial role in expanding the market.
The government of the Philippines, through the Department of Health (DOH) and the Food and Drug Administration (FDA), is actively involved in regulating treatments and devices related to carotid artery disease. Policies focus on ensuring that medical devices and pharmaceuticals used for diagnosis and treatment are safe, effective, and accessible. The Department of Science and Technology (DOST) funds research on carotid artery disease management and promotes innovations in treatment technologies, aiming to improve the quality of healthcare available to patients with cardiovascular conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Carotid Artery Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Carotid Artery Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Carotid Artery Disease Market - Industry Life Cycle |
3.4 Philippines Carotid Artery Disease Market - Porter's Five Forces |
3.5 Philippines Carotid Artery Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Carotid Artery Disease Market Revenues & Volume Share, By Medications, 2021 & 2031F |
3.7 Philippines Carotid Artery Disease Market Revenues & Volume Share, By Surgical Procedures, 2021 & 2031F |
3.8 Philippines Carotid Artery Disease Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Philippines Carotid Artery Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as hypertension, diabetes, and smoking leading to a higher incidence of carotid artery disease. |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of carotid artery disease among healthcare providers and patients. |
4.2.3 Advancements in medical technology and procedures for the diagnosis and treatment of carotid artery disease. |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services and facilities for the diagnosis and treatment of carotid artery disease in remote areas. |
4.3.2 High treatment costs associated with procedures such as carotid endarterectomy or carotid artery stenting. |
4.3.3 Lack of standardized protocols and guidelines for the management of carotid artery disease in the Philippines. |
5 Philippines Carotid Artery Disease Market Trends |
6 Philippines Carotid Artery Disease Market, By Types |
6.1 Philippines Carotid Artery Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Carotid Artery Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Carotid Artery Disease Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.4 Philippines Carotid Artery Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.5 Philippines Carotid Artery Disease Market Revenues & Volume, By Duplex Ultrasound, 2021- 2031F |
6.1.6 Philippines Carotid Artery Disease Market Revenues & Volume, By Compound Tomography, 2021- 2031F |
6.1.7 Philippines Carotid Artery Disease Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.1.8 Philippines Carotid Artery Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Carotid Artery Disease Market, By Medications |
6.2.1 Overview and Analysis |
6.2.2 Philippines Carotid Artery Disease Market Revenues & Volume, By Antiplatelet Drugs, 2021- 2031F |
6.2.3 Philippines Carotid Artery Disease Market Revenues & Volume, By Cholesterol-Lowering Statins, 2021- 2031F |
6.2.4 Philippines Carotid Artery Disease Market Revenues & Volume, By Antihypertensive Drugs, 2021- 2031F |
6.3 Philippines Carotid Artery Disease Market, By Surgical Procedures |
6.3.1 Overview and Analysis |
6.3.2 Philippines Carotid Artery Disease Market Revenues & Volume, By Carotid Artery Angioplasty, 2021- 2031F |
6.3.3 Philippines Carotid Artery Disease Market Revenues & Volume, By Carotid Artery Bypass, 2021- 2031F |
6.3.4 Philippines Carotid Artery Disease Market Revenues & Volume, By Carotid Endarterectomy, 2021- 2031F |
6.4 Philippines Carotid Artery Disease Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Carotid Artery Disease Market Revenues & Volume, By Clinics and Hospitals, 2021- 2031F |
6.4.3 Philippines Carotid Artery Disease Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.4.4 Philippines Carotid Artery Disease Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
7 Philippines Carotid Artery Disease Market Import-Export Trade Statistics |
7.1 Philippines Carotid Artery Disease Market Export to Major Countries |
7.2 Philippines Carotid Artery Disease Market Imports from Major Countries |
8 Philippines Carotid Artery Disease Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for patients with carotid artery disease. |
8.2 Percentage of healthcare providers trained in the latest techniques for the diagnosis and treatment of carotid artery disease. |
8.3 Number of public awareness campaigns conducted to educate the population about carotid artery disease and its risk factors. |
9 Philippines Carotid Artery Disease Market - Opportunity Assessment |
9.1 Philippines Carotid Artery Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Carotid Artery Disease Market Opportunity Assessment, By Medications, 2021 & 2031F |
9.3 Philippines Carotid Artery Disease Market Opportunity Assessment, By Surgical Procedures, 2021 & 2031F |
9.4 Philippines Carotid Artery Disease Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Philippines Carotid Artery Disease Market - Competitive Landscape |
10.1 Philippines Carotid Artery Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Carotid Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |